Malignant

Master case overview

Master file reference

GPRCC-ILL-2020-VP-165478

Illustrative status

Approved

Author / reference identity

Vinay Prasad

Subject area

Health & Medicine

Work

Malignant

Review focus

Health evidence, reader framing and professional terminology. Program questions are selected for this subject area; no passage-level findings are asserted.

Proposed formats · scenario

Print, ebook and audiobook

Proposed market scope · scenario

Selected international editions; territories to be defined in the rights matrix

Book release date

21 April 2020
Johns Hopkins University Press ↗

Registration date · illustrative

28 April 2020

Publication and registration basis

Malignant: Publisher publication date. The modeled registration is seven days after release. Where a source gives only a month or year, dates are shown as a range rather than inventing a day.

Modeled review date

29 May 2020

Source basis

Library title, author, subject mapping and catalog program definitions; no manuscript examined.

Programs & status

This illustrative file covers 7 program records, 28 review controls and 0 open items. Select a program for its review details, document checklist and next action.

Program reference

GPRCC-ILL-2020-VP-165478-HMPC

Master file

GPRCC-ILL-2020-VP-165478

Review scope

Print, ebook and audiobook

Evidence position

4 of 4 controls complete in scenario

Publication context

Malignant by Vinay Prasad · Health evidence, reader framing and professional terminology

Review controls and scoped outcome 4

1. HMPC-101

   Claim classification

   For the proposed scope of Malignant, separate general discussion from diagnostic or treatment claims in the proposed scope. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

2. HMPC-103

   Professional review

   For the proposed scope of Malignant, define the qualifications and scope needed for a proposed specialist review. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

3. HMPC-104

   Reader framing

   For the proposed scope of Malignant, separate educational content from individualized advice. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

4. HMPC-105

   Evidence updates

   For the proposed scope of Malignant, identify time-sensitive health references for later rechecking. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

Completed requirements 4

• Health claim classification ledgerCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: HMPC-101.Submission attempt 1 · 3 May 2020 · reviewed 29 May 2020 · illustrative
• Specialist review briefCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: HMPC-103.Submission attempt 1 · 3 May 2020 · reviewed 29 May 2020 · illustrative
• Reader information wording sheetCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: HMPC-104.Submission attempt 1 · 3 May 2020 · reviewed 29 May 2020 · illustrative
• Health evidence update scheduleCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: HMPC-105.Submission attempt 1 · 3 May 2020 · reviewed 29 May 2020 · illustrative

↑ Back to programs

Program reference

GPRCC-ILL-2020-VP-165478-FCRS

Master file

GPRCC-ILL-2020-VP-165478

Review scope

Print, ebook and audiobook

Evidence position

4 of 4 controls complete in scenario

Publication context

Malignant by Vinay Prasad · Health evidence, reader framing and professional terminology

Review controls and scoped outcome 4

1. FCRS-101

   Claim inventory

   For the proposed scope of Malignant, classify factual, historical and statistical claims selected for the review scope. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

2. FCRS-103

   Context and limitations

   For the proposed scope of Malignant, retain qualifications and avoid widening conclusions beyond their sources. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

3. FCRS-104

   Data reproduction

   For the proposed scope of Malignant, reconcile quoted figures with their source tables and units. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

4. FCRS-105

   Correction control

   For the proposed scope of Malignant, track the edition in which a proposed correction would take effect. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

Completed requirements 4

• Claim-to-source ledgerCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: FCRS-101.Submission attempt 1 · 3 May 2020 · reviewed 29 May 2020 · illustrative
• Claim qualification scheduleCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: FCRS-103.Submission attempt 1 · 3 May 2020 · reviewed 29 May 2020 · illustrative
• Statistical reproduction worksheetCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: FCRS-104.Submission attempt 1 · 3 May 2020 · reviewed 29 May 2020 · illustrative
• Correction and version logCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: FCRS-105.Submission attempt 1 · 3 May 2020 · reviewed 29 May 2020 · illustrative

↑ Back to programs

Program reference

GPRCC-ILL-2020-VP-165478-PFVR

Master file

GPRCC-ILL-2020-VP-165478

Review scope

Print, ebook and audiobook

Evidence position

5 of 5 controls complete in scenario

Publication context

Malignant by Vinay Prasad · Health evidence, reader framing and professional terminology

Review controls and scoped outcome 5

1. PFVR-101

   Credential scope

   For the proposed scope of Malignant, identify exactly which professional claims are proposed for author positioning. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

2. PFVR-102

   Verification sources

   For the proposed scope of Malignant, identify primary sources needed to verify each credential. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

3. PFVR-103

   Jurisdiction wording

   For the proposed scope of Malignant, distinguish academic qualifications from jurisdiction-specific practice rights. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

4. PFVR-104

   Biography consistency

   For the proposed scope of Malignant, align proposed retailer, jacket and speaker biographies. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

5. PFVR-105

   Currency checks

   For the proposed scope of Malignant, identify which professional claims need date-sensitive confirmation. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

Completed requirements 5

• Author credential claim inventoryCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: PFVR-101.Submission attempt 1 · 3 May 2020 · reviewed 29 May 2020 · illustrative
• Credential verification checklistCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: PFVR-102.Submission attempt 1 · 3 May 2020 · reviewed 29 May 2020 · illustrative
• Professional title wording matrixCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: PFVR-103.Submission attempt 1 · 3 May 2020 · reviewed 29 May 2020 · illustrative
• Biography comparison sheetCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: PFVR-104.Submission attempt 1 · 3 May 2020 · reviewed 29 May 2020 · illustrative
• Credential currency scheduleCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: PFVR-105.Submission attempt 1 · 3 May 2020 · reviewed 29 May 2020 · illustrative

↑ Back to programs

Program reference

GPRCC-ILL-2020-VP-165478-AEPC

Master file

GPRCC-ILL-2020-VP-165478

Review scope

Print, ebook and audiobook

Evidence position

5 of 5 controls complete in scenario

Publication context

Malignant by Vinay Prasad · Health evidence, reader framing and professional terminology

Review controls and scoped outcome 5

1. AEPC-101

   Promotional claims

   For the proposed scope of Malignant, match proposed promotional language to documented support. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

2. AEPC-102

   Endorsement consent

   For the proposed scope of Malignant, check scope and permission for any proposed blurb or endorsement. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

3. AEPC-103

   Material connections

   For the proposed scope of Malignant, identify sponsorship disclosures that would be needed for the campaign. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

4. AEPC-104

   Excerpt context

   For the proposed scope of Malignant, retain context when selecting extracts for advertising. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

5. AEPC-105

   Campaign versions

   For the proposed scope of Malignant, keep translated campaign copy aligned with the source version. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

Completed requirements 5

• Advertising claim matrixCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: AEPC-101.Submission attempt 1 · 3 May 2020 · reviewed 29 May 2020 · illustrative
• Endorsement permission checklistCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: AEPC-102.Submission attempt 1 · 3 May 2020 · reviewed 29 May 2020 · illustrative
• Campaign disclosure scheduleCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: AEPC-103.Submission attempt 1 · 3 May 2020 · reviewed 29 May 2020 · illustrative
• Promotional excerpt reviewCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: AEPC-104.Submission attempt 1 · 3 May 2020 · reviewed 29 May 2020 · illustrative
• Campaign version registerCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: AEPC-105.Submission attempt 1 · 3 May 2020 · reviewed 29 May 2020 · illustrative

↑ Back to programs

Program reference

GPRCC-ILL-2020-VP-165478-IMRC

Master file

GPRCC-ILL-2020-VP-165478

Review scope

Print, ebook and audiobook

Evidence position

3 of 3 controls complete in scenario

Publication context

Malignant by Vinay Prasad · Health evidence, reader framing and professional terminology

Review controls and scoped outcome 3

1. IMRC-101

   Fact and opinion boundaries

   For the proposed scope of Malignant, separate editorial interpretation from independently checkable claims in proposed publicity. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

2. IMRC-102

   Non-affiliation wording

   For the proposed scope of Malignant, review references to people and institutions for unintended endorsement implications. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

3. IMRC-105

   Escalation protocol

   For the proposed scope of Malignant, define which disputed statements would require specialist review before reuse. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

Completed requirements 3

• Publicity claim and source ledgerCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IMRC-101.Submission attempt 1 · 3 May 2020 · reviewed 29 May 2020 · illustrative
• Non-affiliation wording sheetCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IMRC-102.Submission attempt 1 · 3 May 2020 · reviewed 29 May 2020 · illustrative
• Media review escalation planCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IMRC-105.Submission attempt 1 · 3 May 2020 · reviewed 29 May 2020 · illustrative

↑ Back to programs

Program reference

GPRCC-ILL-2020-VP-165478-IDLC

Master file

GPRCC-ILL-2020-VP-165478

Review scope

Print, ebook and audiobook

Evidence position

3 of 3 controls complete in scenario

Publication context

Malignant by Vinay Prasad · Health evidence, reader framing and professional terminology

Review controls and scoped outcome 3

1. IDLC-101

   Agreement inventory

   For the proposed scope of Malignant, identify proposed publisher, distributor and retail permissions for the named work. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

2. IDLC-104

   Accounting and reporting

   For the proposed scope of Malignant, document royalty reporting intervals, deductions and audit provisions. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

3. IDLC-105

   Termination controls

   For the proposed scope of Malignant, define takedown, stock sell-off and rights reversion responsibilities. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

Completed requirements 3

• Distribution agreement inventoryCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IDLC-101.Submission attempt 1 · 3 May 2020 · reviewed 29 May 2020 · illustrative
• Royalty and reporting scheduleCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IDLC-104.Submission attempt 1 · 3 May 2020 · reviewed 29 May 2020 · illustrative
• Termination and reversion checklistCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IDLC-105.Submission attempt 1 · 3 May 2020 · reviewed 29 May 2020 · illustrative

↑ Back to programs

Program reference

GPRCC-ILL-2020-VP-165478-IRTC

Master file

GPRCC-ILL-2020-VP-165478

Review scope

Print, ebook and audiobook

Evidence position

4 of 4 controls complete in scenario

Publication context

Malignant by Vinay Prasad · Health evidence, reader framing and professional terminology

Review controls and scoped outcome 4

1. IRTC-101

   Chain of title

   For the proposed scope of Malignant, identify the party authorized to grant rights and reconcile contributor assignments. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

2. IRTC-102

   Territory and format scope

   For the proposed scope of Malignant, map languages, formats, exclusivity and reserved territories without assuming worldwide rights. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

3. IRTC-103

   Edition history

   For the proposed scope of Malignant, separate original publication rights from revised-edition and supplementary-material rights. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

4. IRTC-105

   Reversion and reservations

   For the proposed scope of Malignant, identify expired grants, reserved uses and conflicting options. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

Completed requirements 4

• Ownership and contributor assignment scheduleCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IRTC-101.Submission attempt 1 · 3 May 2020 · reviewed 29 May 2020 · illustrative
• Territory, language and format matrixCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IRTC-102.Submission attempt 1 · 3 May 2020 · reviewed 29 May 2020 · illustrative
• Edition and rights chronologyCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IRTC-103.Submission attempt 1 · 3 May 2020 · reviewed 29 May 2020 · illustrative
• Prior grants and reversion scheduleCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IRTC-105.Submission attempt 1 · 3 May 2020 · reviewed 29 May 2020 · illustrative

↑ Back to programs

Evidence and document index

A modeled evidence schedule for Malignant. These are document requirements and scenario states, not uploaded attachments or manuscript citations.

Consolidated program status

Illustrative review history

Generated milestones showing how this workflow could progress; these events did not occur for the named author.

Program fee breakdown

The original illustrative case total is allocated across the 7 programs below. These example amounts are not payment receipts or quotations.

Total illustrative fees · USD$29,500

These restored case allocations are separate from the planning bands for new quotes. A written scope and quote determine the charge for an actual matter.

Next steps

1. Retain the edition, format and rights schedules modeled in this record.
2. Check proposed changes against each program’s maintenance standard.
3. Reassess new translations, licenses or substantial promotional changes before extending scope.

This sequence describes the modeled approved workflow only.